These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 33072954)

  • 1. Utilising the 'Getting to Outcomes
    Inusa BPD; Anie KA; Lamont A; Dogara LG; Ojo B; Ijei I; Atoyebi W; Gwani L; Gani E; Hsu L
    Int J Neonatal Screen; 2018 Dec; 4(4):33. PubMed ID: 33072954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies to improve healthcare services for patients with sickle cell disease in Nigeria: The perspectives of stakeholders.
    Isa H; Okocha E; Adegoke SA; Nnebe-Agumadu U; Kuliya-Gwarzo A; Sopekan A; Ofakunrin AO; Ugwu N; Hassan AA; Ohiaeri C; Madu A; Diaku-Akinwumi I; Ekwem L; Dogara LG; Okoh D; Jasini J; Girei A; Ekwere T; Okolo A; Kangiwa U; Lawson J; Chianumba R; Brown B; Akinola N; Nwegbu M; Nnodu O
    Front Genet; 2023; 14():1052444. PubMed ID: 36816043
    [No Abstract]   [Full Text] [Related]  

  • 3. Enablers and barriers to newborn screening for sickle cell disease in Africa: results from a qualitative study involving programmes in six countries.
    Archer NM; Inusa B; Makani J; Nkya S; Tshilolo L; Tubman VN; McGann PT; Ambrose EE; Henrich N; Spector J; Ohene-Frempong K
    BMJ Open; 2022 Mar; 12(3):e057623. PubMed ID: 35264367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Multi-centre Survey of Acceptability of Newborn Screening for Sickle Cell Disease in Nigeria.
    Nnodu OE; Adegoke SA; Ezenwosu OU; Emodi II; Ugwu NI; Ohiaeri CN; Brown BJ; Olaniyi JA; Isa H; Okeke CC; Bene BA; Balogun MT; Okocha EC; Aneke JC; Lawson JOJ; Usman AM; Diaku-Akinwumi IN; Okolo AA; Israel-Aina YT; Jamda M; Aworanti OW; Piel FB; Adekile AD
    Cureus; 2018 Mar; 10(3):e2354. PubMed ID: 32181059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White Paper: Pathways to Progress in Newborn Screening for Sickle Cell Disease in Sub-Saharan Africa.
    Hsu L; Nnodu OE; Brown BJ; Tluway F; King S; Dogara LG; Patil C; Shevkoplyas SS; Lettre G; Cooper RS; Gordeuk VR; Tayo BO
    J Trop Dis Public Health; 2018; 6(2):260. PubMed ID: 30505949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptability of Newborn Screening for Sickle Cell Disease among Post-Partum Mothers in Abakaliki, South East Nigeria.
    Nnachi OC; Umeokonkwo AA; Okoye HC; Ekwe AN; Akpa CO; Okoye AE
    West Afr J Med; 2023 Mar; 40(3):298-304. PubMed ID: 37017939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementing newborn screening for sickle cell disease in Korle Bu Teaching Hospital, Accra: Results and lessons learned.
    Segbefia CI; Goka B; Welbeck J; Amegan-Aho K; Dwuma-Badu D; Rao S; Salifu N; Oppong SA; Odei E; Ohene-Frempong K; Odame I
    Pediatr Blood Cancer; 2021 Jul; 68(7):e29068. PubMed ID: 33890391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gaps and strategies in developing health research capacity: experience from the Nigeria Implementation Science Alliance.
    Ezeanolue EE; Menson WNA; Patel D; Aarons G; Olutola A; Obiefune M; Dakum P; Okonkwo P; Gobir B; Akinmurele T; Nwandu A; Khamofu H; Oyeledun B; Aina M; Eyo A; Oleribe O; Ibanga I; Oko J; Anyaike C; Idoko J; Aliyu MH; Sturke R;
    Health Res Policy Syst; 2018 Feb; 16(1):10. PubMed ID: 29433577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community engagement to inform the development of a sickle cell counselor training and certification program in Ghana.
    Anie KA; Treadwell MJ; Grant AM; Dennis-Antwi JA; Asafo MK; Lamptey ME; Ojodu J; Yusuf C; Otaigbe A; Ohene-Frempong K
    J Community Genet; 2016 Jul; 7(3):195-202. PubMed ID: 27090687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a multicenter universal newborn screening program for sickle cell disease in Italy: A call to action.
    Colombatti R; Martella M; Cattaneo L; Viola G; Cappellari A; Bergamo C; Azzena S; Schiavon S; Baraldi E; Dalla Barba B; Trafojer U; Corti P; Uggeri M; Tagliabue PE; Zorloni C; Bracchi M; Biondi A; Basso G; Masera N; Sainati L
    Pediatr Blood Cancer; 2019 May; 66(5):e27657. PubMed ID: 30724025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of gender norms in relation to child's quality of care: follow-up of families of children with SCD identified through NBS in Tanzania.
    Bukini D; Mbekenga C; Nkya S; Malasa L; McCurdy S; Manji K; Makani J; Parker M
    J Community Genet; 2021 Jan; 12(1):143-154. PubMed ID: 32789668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparing newborn screening for the future: a collaborative stakeholder engagement exploring challenges and opportunities to modernizing the newborn screening system.
    Andrews SM; Porter KA; Bailey DB; Peay HL
    BMC Pediatr; 2022 Feb; 22(1):90. PubMed ID: 35151296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of maternal and perinatal mortality in rural and peri-urban settings: what works?
    Kwast BE
    Eur J Obstet Gynecol Reprod Biol; 1996 Oct; 69(1):47-53. PubMed ID: 8909956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Family, Community, and Health System Considerations for Reducing the Burden of Pediatric Sickle Cell Disease in Uganda Through Newborn Screening.
    Green NS; Mathur S; Kiguli S; Makani J; Fashakin V; LaRussa P; Lyimo M; Abrams EJ; Mulumba L; Mupere E
    Glob Pediatr Health; 2016; 3():2333794X16637767. PubMed ID: 27336011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Communication of positive newborn screening results for sickle cell disease and sickle cell trait: variation across states.
    Kavanagh PL; Wang CJ; Therrell BL; Sprinz PG; Bauchner H
    Am J Med Genet C Semin Med Genet; 2008 Feb; 148C(1):15-22. PubMed ID: 18200513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sickle Cell Disease Genomics of Africa (SickleGenAfrica) Network: ethical framework and initial qualitative findings from community engagement in Ghana, Nigeria and Tanzania.
    Anie KA; Olayemi E; Paintsil V; Owusu-Dabo E; Adeyemo TA; Sani MU; Galadanci NA; Nnodu O; Tluway F; Adjei DN; Mensah P; Sarfo-Antwi J; Nwokobia H; Gambo A; Benjamin A; Salim A; Osae-Larbi JA; Ofori-Acquah SF;
    BMJ Open; 2021 Jul; 11(7):e048208. PubMed ID: 34301659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current perspectives of sickle cell disease in Nigeria: changing the narratives.
    Ojewunmi OO; Adeyemo TA; Ayinde OC; Iwalokun B; Adekile A
    Expert Rev Hematol; 2019 Aug; 12(8):609-620. PubMed ID: 31195888
    [No Abstract]   [Full Text] [Related]  

  • 18. Skills Capacity Building For Health Care Services and Research Through the Sickle Pan African Research Consortium.
    Nnodu OE; Osei-Akoto A; Nembaware V; Kent J; Nwegbu M; Minja I; Mazandu GK; Makani J; Wonkam A
    Front Genet; 2022; 13():805806. PubMed ID: 35783259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Methods of Newborn Screening Follow-Up for Sickle Cell Disease Are Highly Variable and without Quality Assurance: Results from the ENHANCE Study.
    Galadanci N; Phillips S; Schlenz A; Ivankova N; Kanter J
    Int J Neonatal Screen; 2024 Mar; 10(1):. PubMed ID: 38535126
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.